» Articles » PMID: 10963357

NACP/alpha-synuclein and Tau Constitute Two Distinctive Subsets of Filaments in the Same Neuronal Inclusions in Brains from a Family of Parkinsonism and Dementia with Lewy Bodies: Double-immunolabeling Fluorescence and Electron Microscopic Studies

Overview
Specialty Neurology
Date 2000 Aug 30
PMID 10963357
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The co-localization of NACP/alpha-synuclein and tau epitopes was examined in the brain stem and hippocampal formation in two patients from a family of autosomal dominant parkinsonism and dementia with Lewy bodies (LBs) without two reported missense mutations in the NACP gene. Double-labeling immunofluorescence study revealed that some brain stem LBs, cortical LBs, pale bodies, Lewy-related neurites, and neurofibrillary tangles expressed both NACP epitopes and the PHF tau AT8 epitope. Double-immunolabeling electron microscopy demonstrated that the NACP antibody selectively labeled 9- to 13-nm-thick straight filaments (LB filaments), whereas AT8 recognized twisted tubules with 80-to 100-nm-interval constrictions in the same neuronal inclusions. We show that NACP and tau aggregate into different filamentous components even if both proteins are incorporated into the same inclusions.

Citing Articles

Distinct subcellular localization of tau and alpha-synuclein in lewy body disease.

Fischer D, Menard M, Abdelaziz O, Kanaan N, Cobbs V, Kennedy R Acta Neuropathol Commun. 2025; 13(1):14.

PMID: 39838428 PMC: 11752823. DOI: 10.1186/s40478-024-01913-w.


Comparative mapping of single-cell transcriptomic landscapes in neurodegenerative diseases.

Shwab E, Man Z, Gingerich D, Gamache J, Garrett M, Serrano G bioRxiv. 2025; .

PMID: 39764045 PMC: 11702568. DOI: 10.1101/2024.12.13.628436.


Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies.

Zhang X, Wang J, Zhang Z, Ye K Transl Neurodegener. 2024; 13(1):40.

PMID: 39107835 PMC: 11302116. DOI: 10.1186/s40035-024-00429-6.


Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.

Langerscheidt F, Wied T, Kabbani M, van Eimeren T, Wunderlich G, Zempel H J Neurol. 2024; 271(6):2992-3018.

PMID: 38554150 PMC: 11136742. DOI: 10.1007/s00415-024-12314-3.


Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration.

Li W, Li J Transl Neurodegener. 2024; 13(1):16.

PMID: 38528629 PMC: 10964635. DOI: 10.1186/s40035-024-00407-y.